Loading...

Zai Lab Limited

ZLABNASDAQ
Healthcare
Biotechnology
$37.17
$-0.60(-1.59%)

Zai Lab Limited (ZLAB) Stock Overview

Explore Zai Lab Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.2/100

Key Financials

Market Cap4.1B
P/E Ratio-15.92
EPS (TTM)$-2.50
ROE-0.33%
Fundamental Analysis

AI Price Forecasts

1 Week$34.66
1 Month$33.43
3 Months$38.63
1 Year Target$8.57

ZLAB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zai Lab Limited (ZLAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.92 and a market capitalization of 4.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;